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Abstract
Objectives: In 2014, immediately prior to the revision of Article 25-2 of the Pharmacists’ Act, we conducted a survey 
on pharmacists’ and patients’ perceptions of pharmacists’ roles. A role discrepancy between the two was identified. The 
objective was to examine changes in role perceptions and awareness of pharmacists as medication specialists following 
revision to the Pharmacists’ Act.
Methods: The survey was conducted using an Internet-based questionnaire. A total of 469 patients and 354 pharmacists 
responded to 12 questions about the perceived roles of pharmacists.
Results: Analysis revealed that the only evaluation that changed as a result of revisions was pharmacists’ role as “family 
or regular pharmacist,” with scores dropping by about half. As in 2014, the high rating rate for pharmacists surpassed 
the high rating of patients for all other items. The greatest discrepancy in role perception was observed for the same 
three items (“Understanding the effects of the drugs the patients are taking,” “Understanding the health changes caused 
by the drugs dispensed to the patients,” and “Consciously protecting patients from the adverse effects of drugs”) as 
2014.
Conclusion: A major role discrepancy continues to exist between patients and pharmacists, and it is necessary for 
pharmacists to take on a more advanced role in patient care. Results suggest that pharmacists must monitor changes in 
patients’ lifestyles and provide clear explanations for patients to rate them highly as medication specialists.
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Introduction
Medicine in Japan is implemented via universal health insur-
ance, which achieves universal healthcare coverage through 
benefits for essential medical services and reduction of out-of-
pocket expenses for the patient.1 However, with increases in 
the older adult population as its most significant long-term 
challenge, the Japanese government is working to shift the 
quality of medical care by expanding primary care and home 
healthcare.2,3 Given these circumstances, influenced by revi-
sions in the Pharmacists’ Act and the medical care system, the 
job of pharmacists is changing from merely dispensing medi-
cations to providing patient counseling and monitoring.4,5
Article 25-2 of the Pharmacists’ Act was revised in June 
2014. This revision indicated that pharmacists’ obligation 
was not only to provide dosing information but also to pro-
vide guidance based on pharmaceutical knowledge. Guidance 
based on pharmaceutical knowledge includes confirmation 
of adherence and assessment of efficacy after handover of 
drugs and provision of ongoing guidance on avoidance of 
side effects and drug interactions.6 As a result of revision of 
this law, Miwa,7 the Japanese Society of Hospital Pharmacists’ 
legal advisor, stated that the role of pharmacists as advisors 
about pharmaceutical use has become clearer.
In March 2014, immediately prior to revision of the 
Pharmacists’ Act, we conducted an Internet survey to investi-
gate pharmacist and patient perceptions of the pharmacists’ 
role based on role theory. Using a US report by Worley et al.8 
as a reference, our previous survey consisted of 4 dimensions 
and 12 items. For all items, pharmacists rated the pharmacist 
role higher than patients, demonstrating role discrepancies. 
The discrepancies in evaluations were greater than those found 
in the US study. Discrepancies in the perceptions of pharma-
cists’ roles were found to appear between pharmacist and 
patient responses, especially for understanding a drug’s effects 
on patients (“The pharmacist knows that the drug a patient is 
taking is effective”), understanding a patient’s physical condi-
tion (“The pharmacist understands the health changes caused 
by the drug”), and awareness of the need to protect patients 
from adverse effects (“The pharmacist is consciously protect-
ing patients from the adverse effects of drugs”). Our Internet 
survey incorporated two new questions designed to have 
patients to evaluate pharmacists’ identity as a medication spe-
cialist in contrast to physicians (“The patient is more likely to 
ask questions about medications to a pharmacist than his/her 
doctor,” and “The patient thinks that a pharmacist is more of a 
medication specialist than a doctor”). A partition analysis of 
our results revealed that respondents who highly rated the 
pharmacist as a medication specialist also had high regard for 
pharmacists as being a family or regular pharmacist, aware-
ness of patients’ use of over-the-counter (OTC) drugs, making 
efforts to be approachable to patients.9
In June 2014 after this survey was conducted, Article 25-2 
of the Pharmacists’ Act was revised. In addition to this revi-
sion to the law, in April 2016, the Ministry of Health, Labor 
and Welfare institutionalized the function of the family/regu-
lar pharmacist as a “medical service covered by health insur-
ance,” with the aim of strengthening “Bungyo,” the 
separation of dispensing from medical practice.10 
Coordinating with the prescribing physician for an integrated 
and ongoing understanding of the adherence status of the 
patient, and the provision of guidance on adherence were 
made subject to health insurance reimbursement. As a result, 
pharmacists were subject to increased responsibilities in 
management of pharmacotherapy in Japanese healthcare.
Numerous researchers in Europe and the United States 
have investigated, from sociological and/or sociopsychologi-
cal perspectives, the changes in pharmacists’ roles resulting 
from advancements in medical technologies and subsequent 
revisions to legal systems.11 Based on sociological role theory, 
Schommer and Gaither conducted a total of six questionnaire 
surveys once every 3 years during the 15-year period between 
1995 and 2010. Specifically, they investigated how patients 
and pharmacists viewed the pharmacist’s role as an advisor 
about the use of pharmaceuticals.12 The researchers reported 
that throughout the 15-year survey period there were no 
changes in patient or pharmacist perceptions about pharma-
cists’ role as advisors on pharmaceutical use and noted that 
pharmacists’ evaluation scores on role perception exceeded 
those of the patients in all survey periods.
Therefore, to investigate changes in perceptions of phar-
macists’ roles from pharmacist and patient perspectives 
resulting from revision of the Pharmacists’ Act and the sys-
tem of medical services covered by health insurance, in July 
2017, 3 years following revisions to the law, we conducted a 
study similar to our previous study. We then compared and 
examined the 2017 findings in light of those obtained in the 
previous survey questionnaire.
Methods
Survey method
Because this study compared perceptions prior to and following 
revisions to the law, the post-revision survey method conformed 
to the pre-revision survey utilized in our previous study.9
We implemented the survey using Internet research 
(Rakuten Research Inc. Company, Shinagawa, Tokyo, 
Japan). The respondents were recruited by Rakuten Research.
Respondent characteristics and selection
The method used to extract respondents was based on the 
survey conducted in 2014. This involved the extraction of 
patients and pharmacists residing in Japan from registered 
monitors by Rakuten Research. This was followed by a pre-
liminary survey to determine whether it was possible to 
obtain the number of respondents needed for this study and 
to collect a distribution of responses that matched the popu-
lation ratio delineated in the Ministry of Internal Affairs and 
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Communications’ basic resident register population by pre-
fecture (as of 1 January 2017). The necessary sample size 
was calculated using Raosoft software, which was estimated 
at the 95% confidence level with a 50% response distribution 
and a 5% margin of error. As the target population size was 
unknown, it was set to 20,000.13 The final estimated sample 
size was determined to be 377; the final sample size was 
taken from a group of 1000 (patients) and 900 (pharmacists) 
to account for approximately 50% and 45% response rate in 
previous survey.
Questionnaire
We employed the same questionnaire used in the previous 
study. In other words, based on role theory, patients and phar-
macists responded to the items with the same meaning using a 
questionnaire designed for both patients and pharmacists 
(Supplemental Figures S1 and S2). The survey method 
remained the same, even if “interpersonal perception theory” 
was employed.9,11 The questionnaire consisted of 12 ques-
tions, and participants responded using a Likert-type 5-point 
rating. The 12 questions represented the following four dimen-
sions: (1) “Communicating with the patient” (Q1–Q4), (2) 
“Understanding the patient” (Q5–Q8), (3) “A family or regu-
lar pharmacist” (Q9, Q10), and (4) “A medication specialist” 
(Q11, Q12). Among the items related to the pharmacist’s role 
communicating with patients, Q4 focused on the same role 
aspect as Q2, which ask about the pharmacist being under-
stood. However, because it was worded from a reverse per-
spective, it queried whether the respondent was able to 
understand the pharmacist. Q4 served as a possible check to 
confirm the consistency of individual responses toward the 
role of a pharmacist being understandable. Since Q4 was 
essentially redundant (i.e. an “inverse” form of Q2), it was 
excluded from the analysis.14,15 Q11 and Q12 asked whether 
patients perceive pharmacists more as medication specialists 
than physicians. We hypothesized that the greater the ratio of 
respondents who gave high points for these questions, the 
greater was the perception of pharmacists as medication spe-
cialists. Thus, they were included in the questionnaire to eval-
uate perception of the pharmacists’ identity.
In addition to Q1 through Q12, patients and pharmacists 
were, respectively, instructed to respond to the following 
three items and two items. Three categorizing variables were 
used with patients: (1) patronage and pharmacy use, (2) fre-
quency/intensity of prescription use, and (3) medical diagno-
ses or conditions. For pharmacists, responses regarding 
practice settings and career length were included as catego-
rizing variables.
Questionnaire implementation
Between 27 and 30 June 2017, Rakuten Research conducted 
a survey of patients registered as monitors for periodic 
Internet polling (Supplemental Figure S1). Between 27 June 
and 7 July 2017, a questionnaire survey was also conducted 
with a sample of pharmacists from the Rakuten Research 
polling database (Supplemental Figure S2).
The respondents participated in the survey of their own 
free will and accord. Moreover, it was explained in advance 
that the questionnaire contained personal information and 
“special-care required” personal information. It was also 
explained that the responses would be handled according to 
Rakuten Research, Inc.’s “Guidelines on protecting personal 
information.” The participants responded to the question-
naire only if they consented.
This study was approved by Josai University’s ethics 
committee on medical research on human subjects (approval 
no. 2018-05A).
Analysis of questionnaire results
Comparison and test methods. Respondents’ characteristics 
were examined using the chi-square test. The ratio of 
responses was determined by dividing the number of 
respondents for each rating (1–5) for each question by the 
total number of valid respondents. The total rate of high rat-
ing (HR) responses (either “4” or “5”) was defined as the 
“high rating” rate.9 Previous studies have used HR as a 
parameter for intergroup comparisons.16,17
Cronbach’s alpha. We calculated Cronbach’s alpha coeffi-
cient and confirmed the survey’s internal consistency among 
each item. If the alpha coefficient was 0.8 or higher, the item 
was regarded as having internal consistency.
Factor analysis. Based on the findings regarding “the concep-
tual structure of the roles of pharmacists” in the previous 
study, we tested the goodness of fit of the confirmatory fac-
tor analysis model in which only one possible common fac-
tor was expected to contribute to the questionnaire results. 
The R package Latent Variable Analysis (lavaan) was used 
for the confirmatory factor analysis.
Partition analysis. For Q11 and Q12 (measuring pharmacist 
identity), we defined the survey response results of “4” and 
“5” (HR) as “1,” and re-defined the response results of “1” 
through “3” as “0,” making them the objective variables. The 
responses for Q1 to Q10 (on a scale from “1” to “5”), exclud-
ing dummy question Q4, were defined as the explanatory 
variables. Partition analysis was then conducted to identify 
the factors that were specific to the group of patients who 
evaluated pharmacists highly as pharmaceutical experts (i.e. 
those who scored Q11 and Q12 highly). To prevent the anal-
ysis results from becoming too complex, branching was 
applied to a maximum of three sub-populations.
Statistical analysis. Partition analysis was conducted using 
JMP 5.1.2 (SAS Institute Japan, Tokyo, Japan) for Windows. 
The R Project for Statistical Computing software package (R 
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version 3.4.1, R Foundation for Statistical Computing, 
Vienna, Austria)18 was used for all other analyses.
Results
In this section, question numbers for Q1 to Q12 will be pre-
sented as abbreviations for brevity and clarity. Figure 1 can 
be consulted to cross-check question number and associated 
content. However, in the discussion, both question number 
and content will be provided for necessary context.
Respondent attributes
The target number of 1000 patient questionnaires and 900 
pharmacist questionnaires was collected. During inspection 
of questionnaire responses, questionnaires with the same 
response selected for Q1 through Q12 were defined as insin-
cere responses and excluded from analysis.19 Data were 
extracted from patient questionnaire response results accord-
ing to the flow shown in Supplemental Figure S3(a). Only 
respondents who regularly visit community pharmacies were 
the target of this study, and respondents, who irregularly sub-
mit prescriptions (for colds and other acute diseases) and 
insincere respondents, were excluded from analysis. In addi-
tion, as shown in Supplemental Figure S3(b), only the 
response results from pharmacists who work at community 
pharmacies were analyzed, and pharmacists not working at 
community pharmacies and insincere respondents were 
excluded from analysis.
By data cleaning, a total of 469 patients and 354 pharma-
cists met the inclusion criteria. The effective response rates for 
patients and pharmacists were 46.9% and 39.3%, respectively. 
The number of patients included in the study decreased pri-
marily because many utilized community pharmacies irregu-
larly (Supplemental Figure S3(a)). For pharmacists, the 
sample size decreased primarily because the respondents did 
not currently work at community pharmacies (Supplemental 
Figure S3(b)). Patients and pharmacists who responded to the 
questionnaire lived in all 47 prefectures throughout Japan, 
demonstrating the general population distribution throughout 
the country. Table 1 shows respondent attributes in the current 
and previous surveys. The only significant result was from dif-
ferent distributions of pharmacists responding in the age cate-
gories for 2014 and 2017, with slightly higher proportions of 
respondents in older age categories in 2017. Cronbach’s alpha 
for patients and pharmacists in the previous questionnaire 
study were 0.88 and 0.85, respectively. In the current survey, 
Cronbach’s alpha coefficients in the patient and pharmacist 
questionnaire were 0.88 and 0.85, respectively, indicating 
internal consistency.
Item analysis
Descriptive statistics for each item are shown in Table 2. No 
ceiling or floor effects were detected in any item.
Comparison of patient and pharmacist HR rate
Table 3 shows the changes in the rate of HR after the revision 
of the Pharmacists’ Act. All HRs from the current question-
naire results of patients and pharmacists corresponded 
extremely well with the values obtained in the previous sur-
vey. The only exception was the HR of pharmacists for Q10, 
which was halved from 41.4% in 2014 to 20.9% in 2017.
In the 2017 results, Q7, Q8, and Q9 produced wide differ-
ences in scores between pharmacists and patients. In the pre-
vious survey, there were wide differences in the scores for 
these three items between the two groups. The results of the 
current survey demonstrated the same pattern, indicating the 
persistence of significant role discrepancies.
Factor analysis. Figure 2 shows the conceptual model of the 
roles of pharmacists based on the results from the previous 
study.9 The following are the goodness-of-fit indices for 
Expressions included in survey items for patients and pharmacists
Q1 The pharmacist makes it easy for the patients to talk to him/her.
Q2 The pharmacist talks by choosing his/her words carefully so that are easily understood.
Q3 The pharmacist understands complaints and responds appropriately.
Q5 The patient thinks that his/her pharmacist knows things about his/her lifestyle habits.
Q6 The pharmacist knows that the patient takes OTC medications and other items.
Q7 The pharmacist knows that the drug a patient is taking is effective.
Q8 The pharmacist understands the health changes caused by the drug.
Q9 The pharmacist is consciously protecting patients from the adverse effects of drugs.
Q10 The patient regards his/her pharmacist as his/her family or regular pharmacist.
Q11 The patient is more likely to ask questions about medications to a pharmacist than his/her doctor.
Q12 The patient thinks that a pharmacist is more of a medication specialist than a doctor.
Figure 1. Comprehensive representation of questions for both patient and pharmacist surveys.
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confirmatory factor analysis of the conceptual structure in the 
previous study for patients (comparative fit index (CFI) = 0.990, 
root mean square error of approximation (RMSEA) = 0.089, 
and standardized root mean square residual (SRMR) = 0.039) 
and pharmacist (CFI = 0.972, RMSEA = 0.123, and 
SRMR = 0.053). Generally, CFI ⩾ 0.95 and RMSEA ⩽ 0.06 
indicate a high goodness of fit, while RMSEA ⩾ 0.10 indicates 
a poor goodness of fit. In addition, SRMR ⩽ 0.08 indicates a 
high goodness of fit.20 The goodness of fit of the conceptual 
model of the roles of pharmacists in the questionnaire results in 
this study was not high enough. However, each index demon-
strated an appropriate goodness of fit within a tolerable range.
Identification of factors related to “medication 
specialists” by partition analysis
The 2017 results in Table 4 show that, in patients with an HR 
on Q11 and ⩾4 on Q10, the percent with HR increased from 
23.5% to 42.3%. Furthermore, if patients also had rated Q2 
with a 5, the HR rate of 58.7%, and if there was a rating of 5 
on Q5, the HR rate rose to 60%. In addition, for those with 
an HR on Q12 and ⩾4 on Q3 in 2017, the percent with HR 
increased from 33.9% to 48.9%. If they also had ⩾4 on Q10, 
the HR rate of 57.7%, and rated Q6 with a 5, the HR rate rose 
to 75.9%. The number of respondents decreased at each step, 
but the specific responses were associated with higher pro-
portional HR rates.
Discussion
The current survey was implemented not only after the revision 
of Article 25-2 of the Pharmacists’ Act, but also after the family 
pharmacist system was newly adopted. The revisions to the 
Pharmacists’ Act and the introduction of the family pharmacist 
system were not found to affect the conceptual structure of the 
roles of pharmacists. The only HR that had changed (as repre-
sented in Table 3) was Q10 (“The patient regards his/her phar-
macist as his/her family or regular pharmacist”). This was 
likely influenced by the recent revision to the law, leading 
pharmacists to feel as though they have not been able to meet 
the roles expected of them. That is, they have not been able to 
fully perform their roles, which may be the reason for the 
observed decline in the pharmacists’ self-evaluations.
The Ministry of Health, Labour and Welfare cites the follow-
ing as the functions they expect of a family or regular pharma-
cist: provision of services at home and 24 h a day; unified 
understanding of medication information, such as continuously 
keeping track of any adverse drug reactions or effectiveness; 
and collaboration with medical institutions, such as providing 
feedback to physicians on adverse reactions and medication sta-
tus.10 However, these functions set a high bar for what is cur-
rently required of family or regular pharmacists, which is 
generally attributed to the difficulty of their implementation.21 
This is inferred from the fact that “family or regular pharmacist 
guidance fee,” an item reimbursed to community pharmacies 
under health insurance, appeared on just 1.28% of all 76,290,000 
prescriptions created in the single year from April 2016 to 
March 2017.21 Based on this, it can be inferred that patients 
rarely experience firsthand the benefits of the functions of the 
family or regular pharmacist that are associated with revision of 
the Pharmacists Act and health insurance system.
Schommer et al. conducted a 15-year longitudinal survey 
on patient and pharmacist views on the roles of pharmacists 
and reported seeing no change in either group. They 
Table 1. Patient and pharmacist characteristics.
Attribute 2017 2014a
 n = 469 n = 529
Patient  
Gender (n, %)
 Male 258 (55.0%) 302 (57.1%)
 Female 211 (45.0%) 227 (42.9%)
 Chi-square, p-value = 0.51
Age (years) (n, %)
 ⩽39 60 (12.8%) 49 (9.3%)
 40–64 315 (67.2%) 386 (73.0%)
 ⩾65 94 (20.0%) 94 (17.8%)
 Chi-square, p-value = 0.09
Duration of drug use (years) (n, %)
 <1 46 (9.8%) 55 (10.4%)
 1–5 180 (38.8%) 200 (37.8%)
 ⩾6 243 (51.8%) 274 (51.8%)
 Chi-square, p-value = 0.95
Number of disease (n, %)
 1 280 (59.7%) 306 (57.8%)
 ⩾2 189 (40.3%) 223 (42.2%)
 Chi-square, p-value = 0.55
Attribute 2017 2014a
 n = 354 n = 338
Pharmacist  
Gender (n, %)
 Male 184 (52.0%) 174 (51.5%)
 Female 170 (48.0%) 164 (48.5%)
 Chi-square, p-value = 0.90
Age (years) (n, %)
 20s 39 (11.0%) 22 (6.5%)
 30s 108 (30.5%) 135 (39.9%)
 40s 111 (31.4%) 104 (30.8%)
 50s 73 (20.6%) 60 (17.8%)
 60s 23 (6.5%) 17 (5.0%)
 Chi-square, p-value = 0.04
Career (years) (n, %)
 <3 33 (9.3%) 26 (7.7%)
 ⩾3 321 (90.7%) 312 (92.3%)
 Chi-square, p-value = 0.44
a2014 research data are cited from Oshima et al.9
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Table 2. Descriptive statistics of the questionnaire results for patients and pharmacists.
Item n
Choice
A: No, not at all B: Yes, definitely
1:
Close 
to A
2:
Fairly 
close to A
3:
Cannot say 
either way
4:
Fairly close 
to B
5:
Close 
to B Average SD
Patient
Q1 469 21 60 151 161 76 3.45 1.05
Q2 469 15 49 84 226 95 3.72 1.00
Q3 469 22 51 167 167 62 3.42 1.00
Q5 469 120 108 146 77 18 2.50 1.15
Q6 469 173 91 93 69 43 2.40 1.35
Q7 469 65 85 126 146 47 3.05 1.20
Q8 469 69 95 147 118 40 2.93 1.17
Q9 469 30 60 173 144 62 3.32 1.06
Q10 469 84 90 132 113 50 2.90 1.25
Q11 469 66 102 191 73 37 2.81 1.10
Q12 469 33 71 206 107 52 3.16 1.04
Pharmacist
Q1 354 2 16 45 186 105 4.06 0.81
Q2 354 2 13 48 212 79 4.00 0.75
Q3 354 2 18 95 213 26 3.69 0.71
Q5 354 6 55 151 132 10 3.24 0.81
Q6 354 13 77 107 144 13 3.19 0.94
Q7 354 4 24 47 215 64 3.88 0.82
Q8 354 3 18 62 207 64 3.88 0.79
Q9 354 2 15 37 179 121 4.14 0.81
Q10 354 43 92 145 55 19 2.76 1.03
Q11 354 6 44 124 140 40 3.46 0.91
Q12 354 2 22 92 161 77 3.82 0.86
Table 3. Comparison of pharmacist and patient high rating rate in 2017.
Item Patient Pharmacist RDb
HR (%) Difference from 2014a HR (%) Difference from 2014a Ph–Pt (%)
Q1 50.5 −0.2 82.2 −0.3 31.7
Q2 68.4 −5.7 82.2 −1.5 13.8
Q3 48.8 −1.1 67.5 −5.0 18.7
Q5 20.3 1.2 40.1 −0.4 19.8
Q6 23.9 −0.7 44.4 0.3 20.5
Q7 41.2 3.4 78.8 −1.4 37.6
Q8 33.7 5.3 76.6 −3.6 42.9
Q9 43.9 1.7 84.7 1.9 40.8
Q10 34.8 2.1 20.9 −20.5 −13.9
Q11 23.5 −0.9 50.8 −0.1 27.3
Q12 33.9 −0.1 67.2 7.7 33.3
HR: high rating; Ph: pharmacist; Pt: patient.
The difference was calculated by subtracting the HR for 2014 from that for 2017.
a2014 research data are cited from Oshima et al.9
bRole discrepancy was defined as the difference between pharmacist HR and patient HR.
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explained this result in terms of dysfunction in the “care and 
respect cycle,” which is a conceptual representation of 
respect for pharmacists and patient care. Thus, they state 
that “without patient care” the patient reacts “without 
respect of the pharmacist,” and in turn, the pharmacist reacts 
“without patient care.”12 Our study also suggests the role of 
pharmacists was not rated highly because patients are not 
enjoying the explicit benefits of family pharmacists.
Factors in the 2014 study that enhanced the HR of Q11 
(“The patient is more likely to ask questions about 
Factor 1 Factor 2 Factor 3
Q1 Q2 Q3 Q5 Q7 Q8 Q6 Q12
e1 e6e2 e3 e5 e7 e8 e12
Factor 1 Factor 2 Factor 3
Q1 Q2 Q3 Q7 Q8 Q9 Q5 Q10
e1 e5e2 e3 e7 e8 e9 e10
(a)
(b)
Figure 2. Model of “the roles of pharmacists”: (a) Patients—Factor 1: communication with the patient, Factor 2: understanding 
the patient, Factor 3: a medication specialist and (b) Pharmacists—Factor 1: communication with the patient, Factor 2: responsible 
monitoring of the patient, Factor 3: a family or regular pharmacist.
This model is cited from Oshima et al.9
Table 4. Factors associated with patient high ratings for pharmacists as medication specialists.
2017 2014a 2017 2014a
 n % of Pt
Q11 ⩾ 4
n % of Pt
Q11 ⩾ 4
n % of Pt
Q12 ⩾ 4
n % of Pt
Q12 ⩾ 4
Original 
data
Additional 
condition
Q11 469 23.5 Q11 529 24.4 Q12 469 33.9 Q12 529 34.0
Q10 ⩾ 4 163 42.3 Q10 ⩾ 2 440 27.1 Q3 ⩾ 4 229 48.9 Q10 ⩾ 4 173 49.7
Q2 = 5 63 58.7 Q1 ⩾ 5 70 50.0 Q10 ⩾ 4 130 57.7 Q1 ⩾ 4 147 53.7
Q5 = 5 40 60.0 Q6 ⩾ 3 34 70.6 Q6 = 5 29 75.9 Q6 ⩾ 4 60 70.0
Ph: pharmacist; Pt: patient.
a2014 research data from Oshima et al.9
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medications to a pharmacist than his/her doctor”), were 
Q10, Q1, and Q6, which changed to Q10, Q2, and Q5 in the 
current study. In addition, factors that enhanced the HR of 
Q12 (“The patient thinks that a pharmacist is more of a 
medication specialist than a doctor”) including Q10, Q1, 
and Q6, changed to Q3, Q10, and Q6 in the current study. 
Based on these results, Q10 (“his/her family or regular 
pharmacist”) appears to be an important factor indicating 
that pharmacists act as medication specialists. In particular, 
patients who gave a high rating of 4 or 5 for Q10 in the 
2017 survey were extracted. According to materials from 
the Ministry of Health, Labour and Welfare, coordination 
with the prescribing physician on duplicate prescribing of 
drugs, confirmation of drug interactions, and adjusting the 
prescription length based on leftover drugs is reportedly 
higher when the family or regular pharmacist guidance fee 
is calculated for health insurance reimbursement compared 
to when this fee is not calculated.22 This suggests the qual-
ity of medical care services provided by pharmacists is 
higher when the family or regular pharmacist guidance fee 
is reimbursed. For this reason, we surmised that patients 
who gave a high rating for Q11 and Q12 were probably 
feeling the benefits of the functions of family or regular 
pharmacists.
The 2014 survey identified Q1 (“The pharmacist makes it 
easy for the patients to talk to him/her”) and Q6 (“The phar-
macist knows that the patient takes OTC medications and 
other items”) as the factors for Q11. However, in the cur-
rently study, this changed to Q2 (“The pharmacist talks by 
choosing his/her words carefully so that they are easily 
understood”) and Q5 (“The patient thinks that his/her phar-
macist knows things about his/her lifestyle habits”). There 
are a number of possible reasons for this finding. For 
instance, there is the possibility that patients had expecta-
tions that pharmacists be not only easy to talk to (Q1) but 
also choose their words carefully to be easily understood 
(Q2). In addition, it could be their increased recognition of 
the need to have pharmacists know not only about their use 
of OTC medications and other items (Q6) but also about 
their lifestyle habits (Q5). Next, a reason for Q1 (“The phar-
macist makes it easy for the patients to talk to him/her”), 
which was identified as the factor for Q12 and changed to Q3 
(“The pharmacist understands complaints and responds 
appropriately”), may be that the patients have come to expect 
pharmacists to be not only easy to talk to (Q1) but also to 
give the appropriate responses (Q3).
The results of this study should be interpreted with sev-
eral study limitations in mind. First, being an Internet survey 
completed by “monitors,” respondents were people who cus-
tomarily collect their information online. Second, although 
data inspection is used to exclude insincere respondents from 
analysis, these responses may not have been removed com-
pletely. Third, the 2014 survey and 2017 survey do not nec-
essarily include the same respondents, so results may be 
affected by sampling variation.
Conclusion
Of the 11 items in the questionnaire concerning pharma-
cists’ roles, the only change that occurred prior to and fol-
lowing the revision of the Pharmacists’ Act was a reduction 
in pharmacists’ score when evaluating their role as a 
“patient’s family or regular pharmacist (Q10).” Based on 
the current consensus in Japan, the reason for this is the 
high bar imposed by the health insurance system for 
becoming a family or regular pharmacist. Difficulty in 
implementing the system may be a background factor.21 
The results of this study showed that the role discrepancy 
between patients and pharmacists that existed prior to revi-
sion of the law has not been resolved. In contrast, follow-
ing the revision, patients appear to expect pharmacists to 
play an even more advanced role than before. Therefore, 
pharmacists must make an even greater effort to narrow 
and resolve the role discrepancy that exists between them 
and their patients.
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